Insider Sell Executive Vice President James Polewaczyk Sells Shares of IDEXX Laboratories Inc - Yahoo Finance
IX1 Stock | EUR 399.90 4.70 1.16% |
Roughly 62% of IDEXX Laboratories' investor base is looking to short. The analysis of current outlook of investing in IDEXX Laboratories suggests that many traders are alarmed regarding IDEXX Laboratories' prospects. The current market sentiment, together with IDEXX Laboratories' historical and current headlines, can help investors time the market. In addition, many technical investors use IDEXX Laboratories stock news signals to limit their universe of possible portfolio assets.
IDEXX Laboratories stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of IDEXX daily returns and investor perception about the current price of IDEXX Laboratories as well as its diversification or hedging effects on your existing portfolios.
IDEXX |
Insider Sell Executive Vice President James Polewaczyk Sells Shares of IDEXX Laboratories Inc Yahoo Finance
Read at news.google.com
IDEXX Laboratories Fundamental Analysis
We analyze IDEXX Laboratories' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
IDEXX Laboratories is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
IDEXX Laboratories Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IDEXX Laboratories stock to make a market-neutral strategy. Peer analysis of IDEXX Laboratories could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics with similar companies.
Peers
IDEXX Laboratories Related Equities
TN8 | Thermo Fisher | 1.28 | ||||
DC4 | DexCom | 0.53 | ||||
DAP | Danaher | 0.13 | ||||
DAP | Danaher | 0.04 | ||||
QTS | IQVIA Holdings | 0.58 | ||||
SHL1 | SIEMENS HEALTH | 0.79 |
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |